BMRN vs EML · P/E 40, rev $1.76B vs P/E 11, rev $121.5M
Biomarin Pharmaceutical Inc (BMRN) versus Eastern Co (EML) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Eastern Co (EML) is a tools & accessories company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported EML revenue for 2026-07-04 was $121.5M. Net income was $6.3M. EML currently screens at market cap $149.4M and trailing P/E 11.4.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. EML currently screens at market cap $149.4M and trailing P/E 11.4.
Not investment advice. Open the BMRN and EML stock pages for the full models.
Not investment advice.